Interleukin-10 Prevents Dendritic Cell Accumulation and Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor Gene-Modified Tumor Cells

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 770-776

  Qin, Zhihai ^a   Noffz, Gabriele ^a   Mohaupt, Mariette ^a   Blankenstein, Thomas ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10;

ANIMAL; ARTICLE; CELL CULTURE; CYTOTOXICITY; DENDRITIC CELL; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MOUSE; PATHOLOGY; PLASMACYTOMA; VACCINATION;

ANIMALS; CANCER VACCINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; MICE; NEOPLASMS, EXPERIMENTAL; PLASMACYTOMA; TUMOR CELLS, CULTURED; VACCINATION;

EID: 0031570843     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Boon, T., J. C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12: 337.
2. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
3. Chen, L., P. S. Linsley, and K. E. Hellström. 1993. Costimulation of T cells for tumor immunity. Immunol. Today 14:483.
4. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283.
5. Huang, A. Y. C., P. Golumbek, E. J. Ahmadzadeh, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
6. Steinmann, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
7. Dranoff, G., E. Jaffee, A. Lazenby, P. Golumbek, H. Levitsky, K. Brose, V. Jackson, H. Hamada, D. Pardoll, and R. C. Mulligan. 1993. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90:3539.
8. Schreiber, H. 1993. Tumor immunology. In Fundamental Immunology, 3rd Ed. W. E. Paul, ed. Raven Press, Ltd., New York, p. 1143.
9. Pisa, P., E. Halapi, E. K. Pisa, E. Gerdin, C. Hising, A. Bucht, B. Gerdin, and R. Kiessling. 1992. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. Natl. Acad. Sci. USA 89:7708.
10. Gastl, G. A., J. S. Abrams, D. M. Nanus, R. Oosterkamp, J. Silver, F. Liu, M. Chen, A. P. Albino, and N. H. Bander. 1993. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer 55:96.
11. Burdin, N., C. Peronne, J. Banchereau, and F. Rousset. 1993. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J. Exp. Med. 177:295.
12. Yamamura, M., R. L. Modlin, J. D. Ohmen, and R. L. Moy. 1993. Local expression of anti-inflammatory cytokines in cancer. J. Clin. Invest. 91:1005.
13. Merlo, A., A. Juretic, M. Zuber, L. Filgueira, U. Luscher, V. Caetano, J. Ulrich, O. Gratzl, M. Heberer, and G. C. Spagnoli. 1993. Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns. Eur. J. Cancer 29:A:2118.
14. Krüger-Krasagakes, S., K. Krasagakis, C. Garbe, E. Schmitt, C. Hüls, T. Blankenstein, and T. Diamantstein. 1994. Expression of interleukin 10 in human melanoma. Br. J. Cancer 70:1182.
15. Smith, D. R., S. L. Kunkel, M. D. Burdick, C. A. Wilke, M. B. Orringer, R. I. Whyle, and R. M. Strieter. 1994. Production of interleukin-10 by human bronchogenic carcinoma. Am. J. Pathol. 145:18.
16. Sher, A., R. T. Gazzinelli, I. P. Oswald, M. Clerici, M. Kullberg, E. J. Pearce, J. A. Berzofsky, T. R. Mosmann, S. L. James, and H. C. Morse. 1992. Role of T-cell derived cytokines in the down-regulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 127:183.
17. Matsuda, M., F. Salazar, M. Petersson, G. Masucci, J. Hansson, P. Pisa, Q. J. Zhang, M. G. Masucci, and R. Kiessling. 1994. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and down-regulates HLA class I expression. J. Exp. Med. 180:2371.
18. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549.
19. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
20. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
21. Peguet-Navarro, J., C. Moulon, C. Caux, C. Dalbiez-Gautzier, J. Banchereau, and D. Schmitt. 1994. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur. J. Immunol. 24:884.
22. Gazzinelli, R. T., I.P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148:1792.
23. Wogensen, L., M. S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J. Exp. Med. 179:1379.
24. Giovarelli, M., P. Musiani, A. Modesti, P. Dellabona, G. Casorati, A. Allione, M. Consalvo, F. Cavallo, F. di Pierro, C. De Giovanni, T. Musso, and G. Forni. 1995. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol. 155: 3112.
25. Suzuki, T., H. Tahara, S. Narula, K. W. Moore, P. D. Robbins, and M. T. Lotze. 1995. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 182:477.
26. Gérard, C. M., C. Bruyns, A. Delvaux, N. Baudson, J. L. Dargent, M. Goldman, and T. Velu. 1996. Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells. Hum. Gene Ther. 7:23.
27. Salazar-Onfray, F., M. Petersson, L. Franksson, M. Matsuda, T. Blankenstein, K. Kärre, and R. Kiessling. 1995. IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. J. Immunol. 154:6291.
28. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10. J. Immunol. 151:2390.
29. Richter, G., S. Krüger-Krasagakes, G. Hein, C. Hüls, E. Schmitt, T. Diamantstein, and T. Blankenstein. 1993. Interleukin 10 gene transfected into chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53:4134.
30. Lupton, S. D., L. L. Brunton, V. A. Kalberg, and R. W. Overell. 1991. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11:1374.
31. Laker, C., C. Stocking, U. Bergholz, N. Hess, J. F. De-Lamarter, and W. Ostertag. 1987. Autocrine stimulation alter transfer of the granulocyte-macrophage-colony-stimulating-factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway. Proc. Natl. Acad. Sci. USA 84:8458.
32. Blankenstein, T., Z. Qin, K. Überla, W. Müller, H. Rosen, H. D. Volk, and T. Diamantstein. 1991. Tumor suppression after tumor cell targeted tumor necrosis factor alpha gene transfer. J. Exp. Med. 173:1047.
33. Hock, H., S. Krüger-Krasagakes, G. Hein, C. Hüls, E. Schmitt, T. Diamantstein, and T. Blankenstein. 1993. Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant. Cancer Res. 53:714.
34. Saito, S., R. Bannerji, B. Gansbacher, F. M. Rosenthal, P. Romanenko, W. D. W. Heston, W. R. Fair, and E. Gilboa. 1994. Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res. 54:3516.
35. Kraal, G., M. Breel, M. Janse, and G. Bruin. 1986. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163:981.
36. Witmer-Pack, M. D., W. J. Swiggard, A. Mirza, K. Inaba, and R. M. Steinmann. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues. Cell. Immunol. 163:157.
37. Jiang, W., W. J. Swiggard, C. Heufler, M. Peng, A. Mirza, R. M. Steinman, and M. C. Nussenzweig. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151.
38. Sallusto, F. M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J. Exp. Med. 182:389.
39. Roake, J. A., A. S. Rao, P. J. Morris, C. P. Larsen, D. F. Hankins, and J. M. Austyn. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin-1. J. Exp. Med. 181:2237.
40. Beissert, S., J. Hosoi, S. Grabbe, A. Asahina, and R. D. Granstein. 1995. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Immunol. 154:1280.
41. Berns, A. J. M., S. Clift, L. K. Cohen, R. C. Donehower, G. Dranoff, K. M. Hauda, E. M. Jaffee, A. J. Lazenby, H. I. Levitsky, F. F. Marshall, R. C. Mulligan, W. G. Nelson, A. H. Owens, D. M. Pardoll, G. Parry, A. H. Partin, S. Piantadosi, J. W. Wimons, and J. R. Zabora. 1995. Phase I study of non-replicating autologous tumor cell injections using cells with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma. Hum. Gene Ther. 6:347.